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Racial Differences in the Incidence of Steroid Diabetes in
Renal Transplant Patients
Francis Dumler, MD,* Hajime Hayashi, PhD,** Jay Hunter, BS,** and Nathan W. Levin, MD^

We have studied the development of steroid-induced diabetes in a population of 143 renal allograft recipients who
were nondiabetic before transplantation.
Steroid-induced
diabetes developed In 9.8% of patients. However, in
blacks its incidence was significantly higher than in whites
(17.3% vs 5.5% respectively; p < .01). The development of
steroid-induced diabetes was not associated with a higher

frequency of HLA-B8 or HLA-Bwl5 in either race. In black
graft recipients, HLA-BI4 was significantly more frequent (p
< .001) among those who developed steroid-induced diabetes than in insulin-dependent diabetic (Type I) and
nondiabetic recipients. The clinical course of patients with
steroid-induced diabetes has been similar to that of noninsulin-dependent diabetics (Type II).

T h e occurrence of diabetes mellitus in renal allograft
recipients who are not diabetic before transplantation has
been well documented, the incidence varying from 6 to
25% (1-6). A greater freq uency of HLA-B8 and Bw15 has
been reported in renal transplant recipients with significant
glucose intolerance which suggests the uncovering of a
latent diabetic state by corticosteroid therapy (7). We have
studied the development of steroid-induced diabetes in a
racially mixed population of renal allograft recipients and
have found a higher incidence of steroid diabetes in blacks
than in whites.

The diagnosis of steroid diabetes was made on the basis of
a negative history for diabetes before transplantation, a
normal fasting blood glucose up to the time of receiving
renal allograft, and the presence of persistent fasting hyperglycemia in the post-transplant period while on chronic
maintenance corticosteroid therapy. HLA typing was carried out on all patients as previously described (8). Fisher's
exact probability test was used for statistical analysis (9).

Results
Of 143 patients who did not have diabetes before transplantation, 14 (9.8%) developed steroid diabetes at varying
times after surgery. Analysis by race of the population at
risk indicated that 9 of 52 blacks (17.3%) developed steroid
diabetes as compared to 5 of 91 (5.5%) whites, a highly
significant difference (p < .01).

Patients and Methods
The population studied consisted of 171 patients who were
transplanted at Henry Ford Hospital during the past seven
years. Of these, 129 were nondiabetic, 28 were juvenileonset, insulin-dependent diabetics (Type I diabetes) diagnosed before transplantation, and 14 developed diabetes
after receiving a renal allograft and while they were on
maintenance corticosteroid therapy (Table I).

The frequency of the HLA antigens B8 and Bwl5 in our
patient population is shown in Table II. None of the white
patients with steroid diabetes was positive for B8 or Bwl5,
and the frequency of Bw15 did not differ between blacks
with steroid diabetes and nondiabetic blacks. Among
blacks with steroid diabetes, the frequency of HLA B14 was
significantly higher (p < .001) than for insulin-dependent
diabetics (Type I) or nondiabetics (Table II). No differences
were noted in the frequency of HLA-B7, B12, or BIB among
black or white nondiabetic, insulin-dependent, or steroidinduced diabetic patients.
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In our patients wfth steroid-induced diabetes, the mean age
was 42 ± 12 years, and the mean duration of onset after
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TABLE I
Steroid-Induced Diabetes in Renal Transplant Recipients:
Racial Distribution
Patient Groups
Nondiabetics
Insulin-dependent
Steroid-induced
Diabetics

Blacks

TABLE II
Frequency (%) of HLA A2, A28, B8, B14 and Bw15 Antigens
in Renal Transplant Recipients

Number of Patients
Whites
Total

43

86

129

13

15

28

Nondiabetics

steroid
Diabetics

(N=86)

(N = 15)

(N=5)

46

63

80

8

5

0

38

27

37

0

B14

10

0

20

Bw15

14

32

0

(N=43)

(N = 13)

HLA A n t i g e n
Whites
A2
A28

9

65

Insulindependent
Diabetics

14
106

171

transplantation was 9 ± 5 months. A positive family history
of diabetes mellitus was present in two of the 14 patients
who developed steroid diabetes. Only one of the patients
with steroid-induced diabetes was obese. There were no
differences in mean body weights between blacks and
whites or between patients with steroid-induced diabetes
and nondiabetic recipients. The frequency of furosemide
usage and its dosage were similar in blacks and whites and
in patients with and without steroid-induced diabetes. All
black patients have required insulin for control of blood
glucose. Two of the five white patients were managed by
diet alone and have a normal glucose tolerance at a lower
steroid dose. No patient has developed ketoacidosis, and
three patients who lost their grafts are no longer diabetic
after corticosteroids were discontinued.

Blacks

(N=9)

A2

33

46

44

A28

19

31

33

B8

9

0

0

B14

2

0

33*

Bw15

2

0

10

* p < . 0 0 1 when compared to nondiabetics and insulin-dependent diabetics (Type I)

association between the development of steroid diabetes
and an increased frequency of HLA-B14.
The mechanisms for the development of steroid diabetes
are not clear. Several effects of corticosteroids may be
relevant, such as an increase in gluconeogenesis, impaired
peripheral utilization of glucose, insulin resistance, and
induction of hyperglucagonemia. It has been recently
shown that steroid therapy, even in renal transplant recipients with a normal glucose tolerance test, results in a
significantly enhanced insulin release and an increased
numberof insulin receptors in monocytes (13). In general,
patients with steroid diabetes are older, are cadaver allograft recipients, have been treated several times for acute
rejection episodes, and acquire their diabetes during the
first three months after transplantation. A family history of
diabetes mellitus is present in one third to one halfof these
patients, and hyperglycemia is usually controlled without
insulin (1-6).

Discussion
The 9.8% incidence of steroid-induced diabetes in our
series agrees with that cited in previous reports (1-6). A
greater frequency of steroid diabetes in blacks has been
reported by David, et al (6), who found a higher frequency
of HLA-A28 in blacks and attributed the greater incidence
of steroid diabetes in blacks to this fact. In our series, even
when we excluded patients who were HLA-A28 positive,
the incidence of steroid diabetes in blacks (15%) was still
higherthan in whites (6%). ft has recently been shown that
HLA-A2 may be a marker for insulin-independent or insulin-requiring diabetes (Type II) in South African blacks
(10). We thus evaluated the frequency of this particular
phenotype among our patients but found no differences
between nondiabetics and steroid diabetics.

We could not find any differences in the type of transplant
(cadaveric or living related), family history of diabetes, total
dose of steroids, and mode of steroid administration (daily
versus alternate day) between patients who developed
steroid diabetes and those who did not. Others have also
found no consistent effect of alternate day steroid therapy
on the development of steroid-induced diabetes (14).
Whether the lower dosages of steroids currently used in
renal transplantation will lead to a decreased incidence of
steroid diabetes remains to be determined. The mean follow-up of these patients is 33 ± 25 months, and complications attributable to steroid diabetes have yet to occur. In

We could not document a higher frequency of HLA-B8 or
Bw15 in steroid diabetics, black or white, as has been
reported previously (7). Others have also failed to reveal
such an association (5). None of our black, insulin-dependent diabetic patients (Type I) was positive for B8 or Bw15.
This finding agrees with reports that indicated no association between the HLA-B locus and Type I diabetes in black
Americans (11,12). However, we did find in blacks an
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this series, steroid-induced diabetic patients did not have
an increase in mortality (10 per 1,000 patient months) when
compared to insulin-dependent diabetics (16 per 1,000
patient months) or to nondiabetic renal transplant recipients (18 per 1,000 patient months).

also suggest that in the black diabetic population renal
failure is more commonly associated with noninsulin dependent (Type II) diabetes (Weiler JW, personal communication). Many socioeconomic and genetic factors may
not only make diabetes more severe in black patients, i.e.,
development of end-stage kidney disease, but may also
predispose them to developing diabetes under certain
stressful c o n d i t i o n s , i.e., maintenance corticosteroid
therapy.

We hypothesize that steroid-induced diabetes as seen in
the renal transplant population is distinct from insulindependent diabetes (Type I) and that clinically it resembles
maturity-onset, noninsulin-dependent (Type II) diabetes
(15). Why blacks are more prone to developing steroid
diabetes is not clear from this study. The population analyzed is a selected one, since all patients have developed
end-stage kidney disease. Analysis of data from the Michigan Kidney Registry for Southeastern Michigan indicates
that diabetes mellitus is more frequently associated with
end-stage kidney failure in blacks than in whites. The data

In summary, these data allow the clinician involved in renal
transplantation to identify a group of patients at particular
risk for steroid-induced diabetes, the black renal transplant
recipient. They also suggest that once diabetes occurs, its
clinical course will be similar to that of Type II diabetes
mellitus and that remission may occur if steroid therapy is
withdrawn.
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